Sign in to fuzzto save your conversations, follow your research and come back anytime.

The Quarter story
The two most recent quarterly results, compared side-by-side.
Uflex delivers a strong profit turnaround in Q1 FY27, driven by volume scale and export growth, though rising debt and soft chemical demand need monitoring.
Revenue grows from ₹18,313 Cr in Q3 FY26 to ₹53,660 Cr in Q1 FY27 — strong demand recovery drives top-line growth
Net debt increases from ₹73,055 Cr in Q1 FY26 to ₹85,875 Cr in Q1 FY27 — leverage rises alongside expansion investments
EBITDA margin expands from 11.0% in Q3 FY26 to 17.0% in Q1 FY27 — improved pricing power boosts profitability
Finance costs grow from ₹1,988 Cr in Q1 FY26 to ₹2,163 Cr in Q1 FY27 — higher borrowing levels pressure interest expenses
Sales volume grows from 74,411 MT in Q1 FY26 to 173,471 MT in Q1 FY27 — capacity expansion captures higher market demand
Chemicals utilization falls from 61.9% in Q2 FY26 to 53.2% in Q1 FY27 — soft regional demand limits segment output
Middle East & Africa revenue share rises from 13.2% in Q1 FY26 to 20.6% in Q1 FY27 — export diversification strengthens regional footprint
India revenue share declines from 49.1% in Q1 FY26 to 41.3% in Q1 FY27 — domestic contribution shrinks as exports gain share
Normalized EBITDA climbs from ₹4,698 Cr in Q1 FY26 to ₹8,373 Cr in Q1 FY27 — operational resilience supports consistent cash generation
Production volume dips from 50,690 MT in Q1 FY26 to 46,929 MT in Q1 FY27 — output stabilizes below earlier peaks amid demand shifts